Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association - PubMed (original) (raw)
Practice Guideline
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Jay S Skyler et al. Diabetes Care. 2009 Jan.
Erratum in
- Diabetes Care. 2009 Apr;32(4):754
No abstract available
Comment in
Similar articles
- Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Skyler JS, et al. Circulation. 2009 Jan 20;119(2):351-7. doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17. Circulation. 2009. PMID: 19095622 No abstract available. - Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Skyler JS, et al. J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. J Am Coll Cardiol. 2009. PMID: 19147051 Review. No abstract available. - [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
Lambiel J, Fumeaux T. Lambiel J, et al. Rev Med Suisse. 2008 Aug 6;4(166):1734. Rev Med Suisse. 2008. PMID: 18777740 French. No abstract available. - The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
Paty BW. Paty BW. Can J Diabetes. 2015 Dec;39 Suppl 5:S155-9. doi: 10.1016/j.jcjd.2015.09.009. Can J Diabetes. 2015. PMID: 26654859 Review.
Cited by
- Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.
De Block C, Peleshok J, Wilding JPH, Kwan AYM, Rasouli N, Maldonado JM, Wysham C, Liu M, Aleppo G, Benneyworth BD. De Block C, et al. Diabetes Ther. 2024 Nov 12. doi: 10.1007/s13300-024-01660-0. Online ahead of print. Diabetes Ther. 2024. PMID: 39531161 - Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.
Khunti K, Zaccardi F, Amod A, Aroda VR, Aschner P, Colagiuri S, Mohan V, Chan JCN. Khunti K, et al. Diabetologia. 2024 Aug 19. doi: 10.1007/s00125-024-06254-w. Online ahead of print. Diabetologia. 2024. PMID: 39155282 - Developing an Exercise Attitudes and Behavior Intentions Questionnaire for Survivors of Aortic Dissection: An Exploratory Factor Analysis.
Feng D, Huang S, Lang X, Liu Y, Zhang K. Feng D, et al. Rev Cardiovasc Med. 2022 Oct 11;23(10):337. doi: 10.31083/j.rcm2310337. eCollection 2022 Oct. Rev Cardiovasc Med. 2022. PMID: 39077130 Free PMC article. - Type 2 diabetes in children and adolescents: Exploring the disease heterogeneity and research gaps to optimum management.
Pramanik S, Mondal S, Palui R, Ray S. Pramanik S, et al. World J Clin Pediatr. 2024 Jun 9;13(2):91587. doi: 10.5409/wjcp.v13.i2.91587. eCollection 2024 Jun 9. World J Clin Pediatr. 2024. PMID: 38947996 Free PMC article. Review. - Physical performance strongly predicts all-cause mortality risk in a real-world population of older diabetic patients: machine learning approach for mortality risk stratification.
Montesanto A, Lagani V, Spazzafumo L, Tortato E, Rosati S, Corsonello A, Soraci L, Sabbatinelli J, Cherubini A, Conte M, Capri M, Capalbo M, Lattanzio F, Olivieri F, Bonfigli AR. Montesanto A, et al. Front Endocrinol (Lausanne). 2024 Apr 30;15:1359482. doi: 10.3389/fendo.2024.1359482. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38745954 Free PMC article.
References
- Reichard P, Bengt-Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309, 1993 - PubMed
- Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993 - PubMed
- Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117, 1995 - PubMed
- UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865, 1998 - PubMed
- UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical